Randomized Trials in Vulnerable Populations
- 1 February 2008
- journal article
- other
- Published by SAGE Publications in Clinical Trials
- Vol. 5 (1), 61-69
- https://doi.org/10.1177/1740774507087552
Abstract
Many persons enrolled in clinical trials can be considered vulnerable, and such trials often raise concerns because of the diminished ability of vulnerable persons to consider and protect their own interests. However, this research is necessary to answer important questions, such as which interventions are effective, which have no impact, and which do more harm than good. In this article, we identified six specific challenges associated with randomized clinical trials in vulnerable populations and have suggested several potential solutions to overcome these challenges. First addressed were macro issues, such as the scope of the problem, and research capacity in terms of funding and investigators. Next, we have addressed research ethics review, informed consent, regulatory hurdles, and serious adverse event reporting. As clinical trials are expanding globally, all stakeholders (investigators, granting agencies, REBs, DSMBs, regulatory bodies, universities, hospitals, clinicians, patients, and family members) should be aware of the challenges we have outlined, and work collaboratively toward effective solutions that improve the quality, quantity, safety, and relevance of clinical trials for vulnerable persons around the world. Clinical Trials 2008; 5: 61—69. http://ctj.sagepub.comKeywords
This publication has 21 references indexed in Scilit:
- Ethics and research in critical careIntensive Care Medicine, 2006
- Vulnerable Populations in Research: The Case of the Seriously IllTheoretical Medicine and Bioethics, 2006
- Reforming research ethics committeesBMJ, 2005
- Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarctionAmerican Heart Journal, 2004
- Research in emergency situations: with or without relatives consentEmergency Medicine Journal, 2004
- Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trialThe Lancet, 2004
- The Limitations of “Vulnerability” as a Protection for Human Research ParticipantsAmerican Journal of Bioethics, 2004
- Impracticability of Informed Consent in the Registry of the Canadian Stroke NetworkNew England Journal of Medicine, 2004
- Obtaining consent for research studies on incompetent subjects: the Quebec experienceIntensive Care Medicine, 2003
- What Makes Clinical Research Ethical?JAMA, 2000